Navigation Links
Progen Investor Teleconference Dial In Details
Date:2/4/2008

BRISBANE, Australia, Feb. 4 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals' Management Team (ASX: PGL; Nasdaq: PGLA) will be conducting an investor teleconference on Tuesday 5 February at 9.00am Australian (Sydney time) and Monday 4 February at 5:00pm US EST.

The Management Team will present an overview of the Cellgate, Inc. acquisition and will be available to answer your queries.
Please refer to the relevant presentation at: http://www.progen-pharma.com

Please follow the dial-in instructions below:

National toll free - Australia - 1800 701 269

Country International Time of Teleconference call

toll free numbers: in the relevant locations

United Kingdom 1080 0264 0084 Monday, 4 February 2008 at 10:00 PM

Hong Kong 800 968 831 Tuesday, 5 February 2008 at 6:00 AM

Japan 0053 125 0068 Tuesday, 5 February 2008 at 7:00 AM

Singapore 800 616 3092 Tuesday, 5 February 2008 at 6:00 AM

Taiwan 008 0161 5152 Tuesday, 5 February 2008 at 6:00 AM

New Zealand 080 044 6041 Tuesday, 5 February 2008 at 11:00 AM

USA 1866 2421 388 Monday, 4 February at 2.00 PM PST

Monday, 4 February at 5.00 PM EST

International toll - + 61 2 8823 6760

Then dial conference identification number: 33563946

If your country is not listed, and you would like to participate on the call, please contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Elusive pancreatic progenitor cells found in mice
2. Imaging neural progenitor cells in the living human brain
3. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
5. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
6. Stryker to Present at Investor Conference
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
8. GSI to Present at Upcoming Investor Growth Conferences
9. WebMD to Present at Upcoming Investor Conferences
10. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
11. Mindray to Attend 2008 CLSA Asia Investors Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology: